Recticel announces results of third quarter of 2013 for different segments. Combined sales decreased from EUR 316.4 million in 3Q2012 to EUR 307.9 million in 3Q2013 (-2.7%). Over the first nine months, combined sales decreased by 5.6% ...
Pulmatrix has released positive results from initial stage of Phase IB clinical trial of a bronchodilator therapy PUR0200 for patients with chronic obstructive pulmonary disease (COPD). The company said PUR0200 is the first small molecule ...
The landscape outside Seville ishellishly hot and dominated by dust. Yet it’s here amid the dry brush and sharp rocks that Hyundai’s WRC test drivers are toiling stoicly on their i20 rally car without an air-conditioned ...
Allegro Ophthalmics has received approval from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to commence two Phase II clinical studies of integrin peptide therapy ALG-1001. The new trials, ...
Tags: Eye Disease Patients
NovaDigm Therapeutics has started a Phase Ib/IIa clinical trial of its NDV-3 vaccine, which is being developed to prevent episodes of vulvovaginal candidiasis (VVC) in patients with recurrent VVC (RVVC). Under the trial, which is a ...
Tags: NDV-3 Vaccine, NovaDigm
US-based biopharmaceutical firm Tracon Pharmaceuticals has started dosing in a Phase Ib clinical of TRC105 for the treatment of patients with metastatic renal cell carcinoma. The trial evaluates the combination of TRC105 and a standard ...
Tags: Tracon, Carcinoma Drug
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, cin its SIMPLE Antibody research program collaboration with Shire Pharmaceuticals' Human Genetic Therapies division. The milestone, which was the first ...
Ceptaris Therapeutics has obtained FDA marketing approval for Valchlor (mechlorethamine) gel to topically treat stage IA and IB mycosis fungoides-type cutaneous T-Cell lymphoma (CTCL) patients who were exposed to skin-directed therapy ...
Tags: Valchlor Gel, Ceptaris
Insurance Board of Nepal (IB) and the German Development Cooperation (GDC) have partnered to enhance micro-insurance in the country with the support of government agencies and financial service institutions. IB and GIZ RFPI Asia, a German ...
Tags: GDC Partner, IB
Sealed Air has introduced the new NewAir IB Anti-Static cushioning film for use on its NewAir IB Express inflatable cushioning system, and is suitable for shipping electronics. The film is said to meet military specifications for ...
Tags: Sealed Air, Protective Film Material, Electronic Products Shipments
The source code for the Carberp financial malware has been leaked online, increasing the risk that other cybercriminals will create their own variants based on it, according to researchers from Russian cybercrime investigations firm ...
Tags: Computer Products, software
Having commissioned over 55 MWp of solar power plants in the UK to date and established itself as a significant participant in the UK solar market with investments in a 50 MWp portfolio of operating solar power plants, ib vogt GmbH is now ...
Tags: Solar, Metallurgy, Mineral, Energy
Danish biotechnology company Zealand Pharma and partner, the Swiss pharma group Helsinn have jointly cHelsinn's Phase IIa study with elsiglutide for the prevention of chemotherapy-induced diarrhea in cancer patients has been completed with ...
Tags: Health, Medicine, biotechnology
Security researchers from Russian cybercrime investigations firm Group-IB have uncovered a cyberfraud operation that uses specialized financial malware to target the customers of several major Australian banks. Over 150,000 computers, ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Spine Wave's intervertebral body fusion device. Producing expandable PEEK spacers, the StaXx IB system will now for the first time offer an expandable device with ...
Tags: FDA, Spine Wave